Metvixia Approval History
- FDA approved: Yes (First approved July 27th, 2004)
- Brand name: Metvixia
- Generic name: methyl aminolevulinate hydrochloride
- Company: PhotoCure ASA
- Treatment for: Actinic Keratosis
Metvixia (methyl aminolevulinate hydrochloride) is a porphyrin precursor used in combination with the Aktilite CL128 lamp for treatment of actinic keratoses.
FDA Approval History for Metvixia
|Jun 27, 2008||Photocure Receives FDA Approval for Metvixia/Aktilite Photodynamic Therapy|
|Jul 27, 2004||FDA Approves Metvixia for Actinic Keratosis|
|Jun 17, 2004||U.S. New Drug Application Approval Expected for Metvix|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.